Cascade Bio, founded in 2022, is making waves in the chemical industry with its innovative approach to biomanufacturing. The company is focused on creating more efficient enzymes aimed at improving the production of sustainable chemicals. With their slogan, "Empowering enzymes to disrupt the chemicals industry," Cascade Bio highlights its commitment to combining natural catalysts with advanced materials for enhanced biocatalysis.
The core of Cascade Bio’s offering is a patent-pending enzyme immobilization platform, which addresses the market demand for stable and durable biocatalysts. Their platform is positioned to play a pivotal role in the emerging bioeconomy, offering an ecologically friendly alternative to conventional chemical processes.
While currently lacking a stated headquarters or last investment details, Cascade Bio's innovative technology positions it as a promising prospect for investors eager to support sustainable industrial solutions. This company represents a significant opportunity in a growing market valuing sustainable practices.